SPDEF and pancreatic neoplasm: Through qRT-PCR and WB analytical methodologies, we ascertained a significant upregulation of SPDEF in pancreatic cancer cells, predominantly within PANC-1 and MIA PaCa-2 lines (Figures 1I and 1J), designating them for further experimental exploration.